MERCK LIMITED (MERCK INDIA), formerly E. Merck Limited, was set up in India as Merck’s first Asian subsidiary in 1967. The company operates both its pharmaceuticals and chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981. The company, as of June 2013, has nearly 1550 employees across its Corporate, Pharmaceuticals and Chemicals business with its manufacturing plant in Ponda, Goa commenced in 1983. Spread across nearly 150,000 sq. m., it has facilities for pharmaceutical as well as chemical manufacturing. In addition to manufacturing injectables and soft gel capsules, Merck India is also the largest manufacturer of Vitamin E in the country.
The biopharma, performance materials and life science (BPL) business of the Company, whose operations solely comprise of (i) the manufacture and trading of prescription medicines for the treatment of cardiovascular disorders, diabetes and thyroid disorders; (ii) trading of effect pigments and functional materials for the automotive, cosmetic, plastic and security industries and the manufacturing of materials for the cosmetic industry; and (iii) trading of products for use by the pharmaceutical and bio-pharma industries, including active pharmaceutical ingredients, excipients and bio-pharmaceutical process chemicals. The company is also the only manufacturer of the chemicals, Guaiazulene, Thiamine Disulphide and Oxynex ST for Merck worldwide. The Dehydrated Culture Media plant that was set up in India in 2008 is the first outside Germany. This business shall not be part of the global transaction with P&G.
Other Group companies in India
Merck Specialities Private Limited (MSPL) is the Indian sales organization of the global Merck Group of Darmstadt, Germany. It supplies the Indian market with high-quality pharmaceutical and chemical products. Established in 2005, this subsidiary is wholly owned by Merck KGaA.
Merck Life Science Private Limited (MLSPL) was incorporated in 1986 as a joint venture with Millipore Corporation, USA and became a 100% subsidiary of Millipore Corporation in 2009. Millipore was acquired by Merck Chemicals in March 2010. Merck Life Science Private Limited India is a leading life science company in the country. Most of the big names in pharmaceutical, biotech, research, F&B and education have Millipore as their preferred partner of choice. Millipore India has been consistently featured in the Top Ten Bioscience Service Providers Ranking compiled by respected industry publications, year after year. The building area is spread across 5,0626 sq ft. in Bangalore. It is ISO 9001:2008 Certified facility. The facility comprises of a main building for domestic manufacturing and Export Oriented Unit (EOU) serving both Global & Domestic customers. It is a single location for manufacturing of Standard Tangential Flow Filtration and Chromatography Purification systems
Merck, a leading science and technology company, announced that it has signed an agreement to sell its global Consumer Health business to Procter & Gamble (P&G) for approximately €3.4 billion (INR 27,200 crore) in cash. The transaction, which is expected to close by the end of the fourth quarter 2018, is subject to regulatory approvals and satisfaction of certain other customary closing conditions. Merck intends to use the net proceeds from the divestiture primarily to accelerate deleveraging. At the same time, it will allow Merck to increase flexibility to strengthen all three business sectors. The divestment of the Consumer Health business is an important step in Merck’s strategic focus on innovation driven businesses within Bio Pharma, Life Science and Performance Materials. Consumer Health is a strong business that deserves the best possible opportunities for its future development.
Currently, the company carries out the Consumer Health business (CH Business) and the BPL Business. As mentioned above, globally MERCK is selling its CH business to P&G and its affiliates.
Please Subscribe to read the full article.